Small-Cap Stocks Outperform in 2024 Amid Sector Rotation

Small-cap stocks have shown notable outperformance against large-cap indices year-to-date in 2024, signaling a potential shift in market dynamics. While the S&P 500 and Nasdaq 100 have seen strong gains, largely driven by a few mega-cap technology stocks, the broader market is experiencing a rotation into smaller companies, particularly within the financials and healthcare sectors. This trend is supported by attractive valuations in small caps and expectations of a more favorable interest rate environment.

The Russell 2000 index, a key benchmark for small-cap performance, has demonstrated this renewed strength. As of June 26, 2026, the Russell 2000 Total Return was up 21.94% year-to-date. This compares to the S&P 500, which was up over 15% in price terms year-to-date as of early July 2024. Analysts suggest that lower valuations for small caps, trading at a 16% discount compared to large caps, make them an attractive investment. Historically, small-cap stocks have often outperformed large caps over the long term, though this trend has not held true in the most recent decade.

The rotation out of technology stocks is directing capital towards sectors like financials and healthcare. Financials are benefiting from expectations of easing economic conditions and potential interest rate cuts, which can improve lending environments and profitability for smaller banks. In healthcare, small-cap biotech and pharmaceutical companies are drawing renewed investor interest due to promising drug pipelines and potential regulatory catalysts, with capital flowing towards innovation-driven healthcare names. This sector rotation is creating opportunities for investors to reassess areas that previously received less attention.

Analysts have identified specific small-cap stocks poised for continued growth. For example, Bank of America highlighted 31 top small and mid-cap stocks for 2024, with a focus on value. These picks include companies expected to increase market share, improve margins, or benefit from mergers and acquisitions, as well as those with unusual growth prospects. The expectation of further interest rate cuts in 2026 from major central banks is also seen as a significant tailwind for smaller companies, which are typically more sensitive to borrowing costs.

For informational purposes only. Not investment advice.

Source: BRZ News research desk. Disclaimer: For informational and educational purposes only and does not constitute financial, investment, or trading advice.